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Abstract
Research concerning person-to-person respiratory virus transmission is required to develop
reliable, evidence-based infection prevention and control measures. Experimental studies of
human coughs were comprehensively critiqued from the point of view of methodologies,
aerodynamics, droplet dispersion and virology. Particle image velocimetry (PIV) and hot-wire
anemometry (HWA) measurements were conducted at x=1 m away from the mouth of
human subjects to develop a model for cough flow behaviour at greater distances from the
mouth than those studied previously. Experiments were conducted for sick subjects who had
presented with influenza-like illness, together with a cohort of healthy subjects. Biological
aerosol sampling was conducted with sick participants to assess the risk of exposure to
airborne viruses. Data were collected and analyzed from 58 subjects, and the results were
used to validate computational fluid dynamics (CFD) models. No differences were observed
between coughs from sick or healthy subjects, and peak cough jet centre velocities as high as
3.05 m/s (Average Vpeak=1.17 m/s) were measured at approximately x/D = 45.
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Chapter 1

1

Introduction

1.1 Background
The spread of respiratory viruses has been a topic of interest to the healthcare
community, as very little is known about the mechanism by which person to person
transmission occurs. There is potential for new strains to emerge and cause severe global
pandemics, in addition to seasonal outbreaks that occur annually. The burden of disease
is greater in countries with middle to low income, and the associated economic costs for
care and lost productivity can be devastating during pandemics (de Francisco et al. 2015;
Lafond et al. 2016). In 2003, the initial severe acute respiratory syndrome (SARS) outbreak
killed 44 Canadians and resulted in the quarantine of 250,000 residents in the city of
Toronto (Aliabadi 2011). In April 2009, the pandemic influenza A (H1N1) first appeared in
North America and spread rapidly around the world (Tellier 2009). By the beginning of
2010, it had caused approximately 17,000 deaths worldwide. An outbreak of Middle East
respiratory syndrome-coronavirus (MERS-CoV) in 2015 in South Korea caused 36 deaths,
and 186 infections were reported (Chang 2017).
Droplets are produced by expiratory such as coughing, sneezing and breathing. Larger
droplets are greatly influenced by gravity, and they are not able to remain airborne for
very long, but droplet nuclei, formed when volatile water content within droplets
evaporates, can remain suspended due to a low settling velocity (Booth et al. 2005). These
droplet nuclei may contain microorganisms which cause infections after contacting
susceptible mucosal surfaces such as the eyes, nose or mouth (Bozzuto et al. 2010).
The potential for infectious droplets to be transmitted from person to person is
influenced by the expiratory jet that propels them. These jets are transient events, which
can be characterized by several parameters typically used to describe both steady free
jets and transient interrupted jets. The peak velocities, directions and spread angles as
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well as the droplet size distributions, concentrations and presence of viable pathogens
are fundamental characteristics of such expiratory events which are necessary to develop
accurate models for airborne respiratory virus transmission. The use of a mask is typically
recommended to interrupt transmission, but experimental evidence has indicated that
the most commonly used masks (N95) are not capable of fully containing cough flow, even
if it has been properly fitted (Tang et al. 2009). Venting or leakage occurs, and the
expiratory jet is merely redirected and diffused.

1.2 Motivation
There is a widespread adoption of the “3-feet, 1 metre,” and “6 feet, 2 metre” rules, which
have been previously indicated as safe separation distances from an infected person
(Kennamer 2007; Deller et al. 2008). These suggestions were not based on experimental
evidence, and the procedures and protocols of avoidance have remained largely
unchanged for decades. The development of models for the production and
transportation of viral aerosols, will hopefully lead to a better understanding of the
mechanism by which person to person transmission occurs, which will assist in the
development of valid infection prevention measures.
Several investigations have been conducted to examine the flow behaviour of coughs at
or near the mouth of human subjects (Gupta et al 2009; Mahajan et al. 1994; Tang et al.
2009; Bourouiba et al. 2014; Nishimura et al. 2013; VanSciver et al. 2011; Afshari et al.
2002; Zhu et al. 2006; Chao et al. 2009), but only one investigation has ever examined
cough flow behaviour beyond this region (Savory et al. 2014). While determining the
cough flow behaviour close to the mouth can be useful for determining boundary
conditions for numerical or physical simulations, the flow behaviour in the far-field is
more important when assessing the potential for virus transmission, since such
separation distances are more common for most human interactions. Statistical issues
arising from a small number of recruited participants provided incentive for the
recruitment of a larger cohort. Any difference in coughs from healthy subjects and those
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who have been infected with respiratory viruses has not been quantified, and biological
aerosol sampling is necessary to estimate the risk of exposure to viable, airborne viruses.

1.3 Thesis scope
The following work contains a comprehensive critical review of experimental
investigations from an engineering point of view. This was the first time that experimental
studies of human coughs have been evaluated simultaneously based on their
methodologies, cough aerodynamics, droplet production and dispersion, and virology.
Following the identification of limitations in our knowledge of the transmission of
respiratory viruses, an experimental investigation was conducted, and data was analyzed
from 77 sets of experiments from 58 different subjects. Throughout the duration of the
investigation, 21 subjects presented with symptoms of respiratory viruses and
participated in “sick” trials. Of these 21, 19 subjects returned for “convalescent” trials,
and a reference “healthy” cohort of 37 subjects was recruited. Point velocity data was
obtained from hot-wire anemometry (HWA) measurements. These measurements were
conducted concurrently with bioaerosol sampling for “sick” trials, and quantitative
analyses of self-collected mid-turbinate swabs identified viral infections. Spatial velocity
fields were recorded using particle image velocimetry techniques (PIV), and the data were
compared with data obtained from a computational fluid dynamics (CFD) model
developed by Bi (2018).

1.4 Objectives
The objectives of the present work were:
1) To review and evaluate previous experimental studies on cough airflow and
aerosol production and transportation, as well as critique the methodologies used
and identify limitations that inhibit our understanding of the transmission of
respiratory viruses
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2) To rigorously test the “3 feet” or “1 metre” rule as supposed safe separation
distances from those who have been infected with respiratory viruses (Kennamer
2007; Deller et al. 2008)
3) To quantify the risk of exposure to viable viral bioaerosols at multiple locations
within the flow field
4) To map the flow field of human coughs at greater distances than those studied
previously, and develop a model for far-field transient cough jet behavior
5) To assess any differences between coughs produced by healthy subjects and those
who have been infected with respiratory viruses
6) To compare the experimental data with the results obtained from computational
fluid dynamics (CFD) investigations, and to draw conclusions on the validity of such
numerical models

1.5 Thesis organization
The thesis was presented in an integrated article format. Following a general introduction
in Chapter 1, a review of experimental investigations is presented in Chapter 2. A modified
version of this chapter was submitted to the journal Aerosol Science and Technology.
Chapter 3 details the experimental methods and contains a comprehensive analysis of
point velocity time histories used to develop a model for far-field cough jet behaviour, as
well as an analysis of the biological data. The experimental results are then compared
with CFD data. A modified version of Chapter 3 will be submitted to a journal for review
in Fall 2018. Chapter 4 provides an analysis of the spatial velocity distributions and
characteristics determined experimentally to complete the model for far-field cough
airflow. Finally, Chapter 5 contains a summary of the conclusions obtained from the
investigations and a discussion of the objectives. Recommendations for future work and
analysis were also provided in Chapter 5.
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Chapter 2

2

Respiratory virus transmission: A review of
experimental cough airflow and aerosol studies

2.1 Introduction
The spread of respiratory viruses has been of intense interest to the healthcare
community. Seasonal outbreaks of influenza virus occur annually and there is potential
for new strains to emerge and cause severe global pandemics. Respiratory viruses are
responsible for a proportion of acute upper and lower tract infections, thus conferring a
significant burden of disease with associated economic costs for care and lost productivity
(de Francisco et al. 2015; Lafond et al. 2016). In April 2009, the pandemic influenza A
(H1N1) first appeared in North America and spread rapidly around the world (Tellier
2009). By the beginning of 2010, it had caused approximately 17,000 deaths worldwide.
In addition, novel zoonotic pathogens have spilled over to humans from animal hosts,
leading to sustained person-to-person transmission. In 2003, the initial severe acute
respiratory syndrome (SARS) outbreak killed 44 Canadians and resulted in the quarantine
of 250,000 residents in the city of Toronto (Aliabadi 2011). An outbreak of Middle East
respiratory syndrome coronavirus (MERS-CoV) in 2015 in South Korea caused 36 deaths
and 186 infections were reported, demonstrating how much is still unknown about the
mechanisms influencing transmission (Chang 2017).
Human respiratory activities, such as coughing, sneezing, breathing and talking, are
responsible for dispersion of pathogens through the air. These expirations generate the
smallest aerosols, compared to other sources, and these expired aerosols are particularly
important in the spread of infection among hosts (Morawska 2006). Coughing is
considered a transient, multiphase turbulent flow that is generally composed of buoyant
warm air with suspended droplets varying in size. These droplets can contain pathogens
and minerals that form droplet nuclei after evaporation of the droplet’s water content
(Tellier 2006). It has been demonstrated that the expired viruses are protected by mucous
when travelling through the air and they retain their infectivity (Kormuth et al. 2018).
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Many parameters govern the characteristics of a cough flow, such as mouth opening area,
flow rate, direction, temperature, the size distribution of the virus droplets and the
quantity of viral agents in the droplet (Gupta et al. 2009).
People with existing health conditions are more susceptible to infections (Kennamer
2007; Public Health Agency of Canada 2015). During an influenza pandemic, healthcare
workers are at greater risk of exposure to the virus, as they care for an increased number
of infected patients. Infectious agents can be transmitted by direct or indirect contact via
droplets or droplet nuclei (Deller et al. 2008). Direct transmission occurs when the
transfer of microorganisms results from direct physical contact between an infected
individual and a susceptible host. Droplet transmission occurs when respiratory droplets,
generated via coughing, sneezing or talking, contact susceptible mucosal surfaces such as
the eyes, nose or mouth. This review focusses solely on coughs as the frequency and
magnitude of these expiratory events means there is the potential for a large number of
infectious droplets to be introduced into the environment. Due to their large size, many
respiratory droplets are not able to remain suspended in the air (Booth et al. 2005).
Airborne transmission refers to infectious agents that are spread via droplet nuclei
containing microorganisms. These organisms can survive outside the body and remain
suspended in the air (Bozzuto et al. 2010).
The World Health Organization (WHO) expends significant effort to prevent and control
disease outbreaks (Tang et al. 2006), but experimental studies involving human
participants are limited, and the relative contribution of each mode of transmission
remains unclear. Previously assumed safe separation distances of 1 m or greater
(Kennamer 2007; Deller et al. 2008) are not evidence based, even though such
information is crucial. To develop efficient infection control measures in healthcare
facilities, the pathways by which the disease transfers from person-to-person need to be
identified and interrupted.
The objective of this review is to critique experimental approaches, identify gaps in our
knowledge and issues that impede our progress. The aerodynamic characteristics,
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expiratory aerosol distributions, and topics dealing with virus viability are introduced, and
the methods used are evaluated separately, from an engineering perspective to examine
the factors influencing the persistence of viable influenza virus in human coughs. Finally,
recommendations for modelling cough jet behaviour will be presented, based on key
experimental findings. These recommendations can be used in the development of
physical, mathematical or computational fluid dynamics (CFD) models.

2.2 Aerodynamic characteristics of cough jet flow
The factors that govern the cough jet flow dynamics are: exhaled velocity, flow rate,
direction, and mouth opening area. These factors can be considered as transient
boundary conditions for cough flow (Gupta et al. 2009). This section examines these
factors as well as the experimental methods used to measure them.

2.2.1

Methodologies

The following section reviews the experimental methods used to measure airflow
characteristics of human coughs and critiques them from an engineering perspective.
Recommendations are made based on the ability of each method to adequately measure
the cough airflow.

2.2.1.1

Spirometry

Several methods, varying in accuracy and certainty, have been used to evaluate the
behaviour of cough flow at the mouth. Flow rates and expired volumes have typically
been studied using spirometry techniques (Gupta et al. 2008; Mahajan et al. 1994;
Goldsmith et al. 2010; Lindsley et al. 2010). For this approach, subjects coughed into a
mask and the flow rate was determined from the pressure drop over numerous parallel
capillary tubes. Such techniques are very sensitive to temperature, humidity and
atmospheric pressure, and the equipment must be frequently calibrated. The results
provided little information on how the cough flow field develops beyond the initial region
at the mouth, or the role it plays in particle transport. Such information is crucial in
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developing infection prevention methods and mitigating virus transmission through air
handling and personal protective equipment.

2.2.1.2

Schlieren imaging

Schlieren imaging has previously been used by Tang et al. (2009) as a method of visualizing
cough airflows. The average human exhalation temperature was determined to be 33.935.5°C (McFadden et al. 1985), and the difference in density between expired air and
ambient air (20.0-25.0°C) refracts light, while a camera can only detect a planar image of
the three-dimensional flow field. A benefit to using this non-intrusive technique is that
no extraneous seeding particles or gases are required, but the flow field could only be
measured in the region close to the mouth, where the temperature gradients were high
enough to be detected. In this study, 16 measurements were obtained from 10 subjects,
with images recorded at 3000 fps, with a 1 µs exposure time. Fine scale turbulent eddies
were visible in the images, without visual smearing, and the velocities were determined
by tracking the spatial movement of these eddies. The field of view was 1 m in diameter,
and it contained the participants whole head in each image. The authors did not comment
on the accuracy of the method, and uncertainty in the calculated velocity profile is
expected since the optical system recorded a projection of the three-dimensional flow
field. This means that the eddy tracking velocimetry techniques employed may not be
suitable.

2.2.1.3

Video imaging

Other studies have visualized cough flow using high speed (300 fps) (Nishimura et al.
2013) and moderate speed (120 fps) (Gupta et al. 2009) photography. Both experiments
had participants inhale cigarette smoke, and cough in front of a camera that tracked the
motion of micro-clouds of smoke. Due to the risks associated with the inhalation of
cigarette smoke, a safe alternative must be used for the method to be acceptable. There
is also a possibility that a cough produced by a smoker is not representative of those
produced by healthy subjects or those naturally infected with respiratory viruses. Gupta
et al. (2009) determined cough jet directions and spread angles with the technique,
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whereas Nishimura et al. (2013) subjected their images to vector analysis to determine
the velocity field. There was substantial uncertainty involved in using this method, and
the vector fields are deemed incomplete since only the apparent clouds of smoke were
visually tracked by the camera. A maximum velocity error of approximately 1% was
calculated by the authors. Their study was primarily concerned with the evaluation of a
new measurement techniques. The field of view was approximately 143 cm x 83 cm and
it contained the subject’s head and torso. Images had a resolution of 640 x 400 pixels and
so another limitation of the study was the low spatial resolution of the measurements.

2.2.1.4

Particle image velocimetry

Particle image velocimetry (PIV) has commonly been used to spatially resolve velocity
fields, within a specified field of view. PIV techniques are non-intrusive, and they usually
involve the optical tracking of tracer particles that are illuminated by a laser sheet. Zhu et
al. (2006) conducted experiments using an unspecified, particle laden tracer gas
suspended within the experimental chamber to seed the flow. However, with a field of
view of 100 mm x 100 mm located at the mouth and a capturing frequency of 3.75 Hz,
much of the cough jet flow is missed both spatially and temporally. Another limitation
stems from the recruitment of only three participants for the study. A more extensive
study by VanSciver et al. (2011) used a similar capturing frequency but aerosolized stage
fog particles (typically 1-10 µm diameter) were used as seeding. A larger cohort of 29
subjects was recruited, and experiments were conducted within a 1200 mm x 670 mm x
760 mm enclosure. Although the dimensions of the field of view were not specified,
measurements were taken directly at the mouth. In another study, Chao et al. (2009)
recorded images at 5 Hz within an 800 mm long acrylic tube, 500 mm in diameter. The
experimental field of view was 45 mm x 60 mm, located at the mouth. Aerosols of a saline
solution were used to seed the flow. The study recruited 11 participants. For their
experiments, Kwon et al. (2012) recorded image pairs at a higher frequency of 14.5 Hz.
Their 247 mm x 184 mm field of view was, again, located at the mouth and aerosolized
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olive oil droplets were used as seeding particles. Each of the 27 participants was asked to
cough 3 times for this study.
Prior to a study by Savory et al. (2014), cough flow has been primarily examined in the
region adjacent to the mouth of participants. This provided motivation for a set of PIV
experiments where measurements of cough airflows were recorded, at 16.7 Hz, in a 233
mm x 175 mm field of view, centred 1 m downstream from the subject. A novel
experimental chamber, with dimensions of 1.81 m x 1.81 m x 1.78 m, was filled with
aerosolized titanium dioxide (TiO2) particles. The particles used were 0.15-0.47 µm
diameter, so there was less of an influence due to gravity than the previously mentioned
larger stage fog or olive oil particles.

2.2.1.5

Simulated coughs

Due to the unpredictable nature of conducting experiments with human subjects, several
studies have developed and investigated the use of cough simulators (Afshari et al. 2002;
Wei and Li 2017; Lindsley et al. 2013; Zhang et al. 2017). This introduced repeatability in
experiments but often required many simplifications. Afshari et al. (2002) used a hydraulic
pump to feed flow through a 50 mm diameter inlet pipe. Wei and Li (2017) also designed
a cough simulator for their experiments, but they used a piston-cylinder to force water to
flow through large (10 mm) and small (4 mm) nozzles. The stream-wise penetration
distance and particle transport characteristics for sinusoidal, pulsation and real cough
piston actuation (based on the profile obtained by Gupta et al. (2009)) cases were studied.
Another simulator designed by Lindsley et al. (2013) used a linear motor to actuate a set
of cylindrical bellows according to a lognormal cough profile through a nozzle (21 mm
diameter), while aerosols of a cell culture medium were generated with an airbrush and
a nebulizer. The setup was used with a similar breathing simulator in a simulated medical
examination room to estimate the risk of exposure to airborne aerosols (Lindsley et al.
2012). Zhang et al. (2017) developed another novel simulator using a solenoid valve to
control flow from a pressurized air cylinder. Again, a nebulizer is used to simulate cough
aerosol particles, but the fluid in these experiments consisted of a distilled water, glycerin
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and sodium chloride solution. However, their method could not actuate a cough velocity
profile that was representative of an actual human cough. The use of a cough simulator
may be beneficial when conducting experiments with particles that contain a virus, since
the exposure to viable viral aerosols can be measured without the risk of infection.
However, many factors influence the flow field of a cough and, in all mentioned
simulations, substantial oversimplifications are present. Even if the nozzle opening area
is similar to the measured mouth opening areas during coughs, the complex geometry
and time dependent behaviour of the mouth likely affects the flow field. It is also difficult
to draw meaningful similarities when the working fluid is not air.
For experiments regarding cough jet flow behaviour, PIV has proven to be the most
suitable technique. However, it is important that the measurement window contains the
entire cough width, and it is important that images are recorded at a frequency great
enough to capture most of the cough dynamics. Seeding particles with a very low settling
velocity must be selected.

2.2.2

Cough airflow characteristics

The following section compares the results of several experimental investigations
concerning the aerodynamics of human coughs. Recommendations for modelling such
flows are made based on the values obtained experimentally.

2.2.2.1

Cough expired volume (CEV)

The total volume of air expired during a coughing manoeuvre can be used as a limit for
the total pathogen bearing volume introduced into the air. However, a wide range of
values (from 0.25-4.8 L) have been obtained experimentally for the CEV (Figure 1).
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Figure 1: Cough expired volumes and range of experimental results (when given)
Mahajan et al. (1994) and Lindsley et al. (2010) had determined average CEV values that
were greater than any of the coughs measured by Zhu et al. (2006) and Gupta et al. (2009).
In their experiments, subjects were asked to inhale as much as possible and cough
forcefully, using all the air in their lungs. The instructions that the subjects received may
have biased the CEV towards larger values which may not have been representative of a
naturally occurring cough. High variability demonstrates that numerical simulations of
human coughs should consider incorporating a wide range of conditions, rather than
focusing on a single representative flow. It is evident that the experimental data used to
validate any model must be retrieved from a cohort of participants large enough to
represent the general population, with a large enough number of coughs to draw
statistically significant conclusions. It is also necessary to collect data from a cohort of
participants who have been infected with respiratory illnesses, to asses any difference in
the airflows of sick and healthy coughs. Lindsley et al. (2010) had conducted their
experiments with subjects who were naturally infected with influenza, but only a slight
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difference in the average CEV was noticed. Based on the evidence, with emphasis on
those who were asked to cough naturally, it is recommended that a CEV of approximately
0.85 L is used for modelling purposes. This value was calculated as the average CEV for all
participants obtained by (Gupta et al. 2009), since this was the largest set of experimental
data concerning natural coughs.

2.2.2.2

Cough peak flow rate (CPFR)

The peak flow rate of a cough can indicate its ability to transport pathogens to greater
distances. Figure 2 summarizes the peak flow rates obtained from several different
spirometry studies.
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Figure 2: Cough peak flow rates and range of experimental results (when given)
The CPFR was between 1.6-14.2 L/s. The experimental results show a very high initial
acceleration in the exhaled fluid followed by a rapid decay, although there are some
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discrepancies in the peak velocity times (PVT) measured. Gupta et al. (2009) determined
that the peak velocity was reached between 57-110 ms, whereas a range of 9-49 ms was
observed by Mahajan et al. (1994). The difference in PVT may have been attributed to the
higher velocities produced by subjects in the experiments of Mahajan et al. (1994). A
cough with a higher velocity is expected to have a shorter PVT. The mouth opening area
has only once been determined experimentally by Gupta et al. (2009). The area was
approximately constant (4.00±0.95 cm2 for males and 3.75±1.4 cm2 for females) for a
period of 0.20 sec, when there was flow from the mouth. Based on a mouth area of 4.00
cm2 and a maximum measured flow rate of 14.2 L/s, there is potential for cough speeds
as high as 35 m/s to occur. When modeling cough flow, a CPFR of 6.0-8.0 L/s may be
reasonably selected as a representative, strong cough, based on the available evidence.

2.2.2.3

Maximum cough velocity

While volumetric studies have provided information on the limits of the expiration
capabilities of human lungs, velocity measurements have provided data on how cough
jets transport droplets through the ambient air. Figure 3 summarizes the maximum cough
velocities determined at the mouth of coughing human subjects.
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Figure 3: Maximum cough velocity obtained at the mouth of subjects
Despite the wide range of velocities noticed, average initial airspeeds on the order of 10
m/s were identified in several studies. However, due to the low sampling rates of some
investigations, it is possible that the momentary peak velocity was greater, but not
recorded within a PIV image. Many experiments have determined the initial cough
velocities at the mouth of subjects, but data concerning the flow field at greater distances
from the mouth is scarce. It has been indicated that, in future work, the cough flow should
be mapped at greater distances from the mouth to evaluate the far field velocities and jet
width, and to better determine the cough’s penetration into a room (VanSciver et al.
2011). Due to the high initial velocities experienced in a cough, there is a strong possibility
that infectious droplet nuclei can be transported well beyond the previously studied fields
of view. It is important to understand particle transport characteristics in the far field to
better understand factors that influence virus transmission.
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2.2.2.4

Cough direction and spread angles

Due to the geometry of the mouth and nose, expired cough flows travel downward
instead of horizontally. These jets also entrain ambient air into the flow causing them to
spread out in the environment. The direction of the downward jet has been defined with
two angles: θ1 and θ2 (see Figure 4). The 95% confidence bounds for the mean angles
were determined to be: θ1=15 ±5°, θ2=40 ±4°, with no distinction identified between male
and female subjects (Gupta et al. 2009). By subtracting the directional angles, an
approximate spread angle of 25° is calculated. A similar spread angle of 24° was
determined by Tang et al. (2009). However, Kwon et al. (2012) calculated spread angles
of around 38° for males and 32° for females. This appears to contradict the previous
results, but the spread angle was calculated from the angle created by the maximum
observed u- component velocity and the and maximum upward and downward vcomponent velocity. It is expected that if the spread angles were measured from the
images of the flow field, the resulting angle would have been consistent with the previous
experiments.
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Figure 4: Cough jet angles (adapted from Gupta et al. 2009), θ1=15 ± 5°, θ2=40 ± 4°, θ=25
± 9°

2.2.2.5

Far-field measurements

While numerous experiments have studied cough flows at the mouth, the strength of
coughs at greater distances (1 m, or approximately 50D downstream based on the
average mouth opening diameter of approximately 0.02 m measured by Gupta et al.
2009), has only been quantified by one PIV study (Savory et al. 2014). Each cough had a
significant variation in strength and direction. The data show significant air motion, with
a mean peak spatially averaged velocity of 0.41 m/s, casting doubt on previously assumed
safe separation distances (Kennamer 2007; Deller et al. 2008). The study showed that the
cough velocity profile has no single characteristic shape and, thus, the measurement and
analysis of a larger number of coughs than those examined in these initial trials, was
considered essential to determine a well-defined far field cough velocity profile. The PIV
window size and the variable physical traits of the study participants induced some
limitations on the study.
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2.3 Expiratory aerosol size and concentration
Respiratory activities extrude droplets, which will not totally evaporate, since they
contain substances besides pure water, such as electrolytes, mucus, glycoproteins,
enzymes, antimicrobial agents and microorganisms (Bozzuto et al. 2010). Droplet nuclei
exist when volatile droplet water evaporates leaving behind a nucleus of nonvolatile
substances (Figure 5).

Figure 5: Evaporation of a liquid droplet to form a droplet nucleus (adapted from
Verrault et al. 2007)
The evaporation of falling droplets was first studied by Wells (1934). Using a simple
calculation method, he obtained a classical curve that revealed the relationship between
droplet size, evaporation and settling rate. However, to account for the velocities present
during a cough or a sneeze, a similar mathematical model was developed by Xie et al.
(2007) which demonstrated that a particle with a specific diameter either evaporated
completely if the diameter was less than the vertex value, or it fell to the ground if the
diameter was greater (Figure 6). The amount of time that a particle took to complete its
trajectory decreased as the jet velocity increased, and a higher velocity caused the vertex
value to shift towards a smaller diameter (along the dotted vertex boundary line). This
means that droplets evaporate sooner if they were expired at a greater velocity,
indicating the influence of the droplet size distribution on the spread of infections, but
the effect of the collision and agglomeration of droplets was neglected. The droplet size
distribution dictates the capacity of a particle to remain airborne and it can determine the
ability of a particle to penetrate deeper into the lungs. In humans, those particles with
diameters larger than 10 µm will not pass the upper airway (Thomas 2013). Experimental
investigations have determined particle sizes and concentrations to develop and validate
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models for cough behaviour, but there are limitations in the methods available for particle
sizing and counting experiments, as will be discussed in the next section.
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Figure 6: Time taken for particles to evaporate completely (left side of dotted boundary
line) or fall to the ground (right side of line) (adapted from Xie et al. 2007)

2.3.1

Methodologies

The following section reviews the experimental methods used to measure distributions
of droplets expired by human coughs and critiques them from an engineering perspective.
Limitations in the methods available are identified, and recommendations are made
based on the ability of each method to adequately measure the distributions.

2.3.1.1

Microscopy

The earliest investigations of droplet size utilized solid impaction and micrometry
techniques (Duguid 1946). A dye was introduced into the mouth of a participant and the
subject was asked to cough freely onto a celluloid slide, typically placed within 15 cm of
the mouth. The stain marks, produced by the dyed particles, were then counted and
measured with a microscope. However, the stain diameters partially consisted of
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flattened particles, so the actual particle size was simply estimated to be half of the stain.
The experimental techniques were completely insensitive to smaller droplets (<5 µm)
(Duguid 1946) and they underestimated the total number of particles, as well as the
number of smaller particles (5-10 µm) (Nicas et al. 2005).
Loudon & Roberts (1967) utilized two different techniques to investigate the size and
number of expired particles during talking and coughing. Three subjects were asked to
cough into a small chamber with a volume of 0.057 m3. Similar to Duguid (1946), a dye
was introduced into the mouth of the participant, which deposited onto the paper lining
on each of the walls within the chamber following a cough. Air was then drawn out of the
chamber through a 0.43 µm Millipore filter. Stain marks on the paper and filter were
measured through microscopy. The authors assumed that particles with a stain diameter
<10 µm had the same diameter when airborne. Larger particle sizes were adjusted
downward according to a regression based on the experimental results of separate
experiments investigating the stains left on paper by particles between 35-280 µm.

2.3.1.2

Interferometric Mie imaging (IMI)

Interferometric Mie imaging (IMI) has also been used to measure particles suspended in
cough jets (Chao et al. 2009). When a transparent droplet passed through a laser sheet
positioned either 10 mm or 60 mm from the participant, refraction and reflection
occurred. Rectangular fringes, which are mathematically related to the droplet diameter,
were observed within a 6.7 mm x 8.9 mm x 1 mm measurement plane by a CCD camera
positioned at an angle of 80° to the laser sheet. Images were recorded at 10 Hz, meaning
that much of the cough was missed. This imaging technique can only detect particles
larger than 2 µm and only transparent droplets can be measured. Particles are assumed
to be spherical for calculations.

2.3.1.3

Optical particle counting (OPC)

Optical particle counting (OPC) techniques have been employed to investigate particles
in the sub-micrometre range (Papineni & Rosenthal 1997). In this technique, particles
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were illuminated by a high intensity light source and the scattered light was observed
with a photoreceptor. Particles as small as 0.3 µm can be detected and, in their
experiments, measurements were taken before the particles completely evaporated.
However, measurements cannot be performed within the natural flow field of the cough.
Instead, the airflow must be sampled and particles then pumped or directed into a port
for sizing. OPC techniques are highly susceptible to error in sizing since the optical
properties of the measured aerosol greatly influence the accuracy. If the instrument is
not calibrated for the specific aerosol being measured, the diameter measurements can
be in error by a factor of 2 (Liu & Daum 2000). The instruments are usually calibrated with
polystyrene latex spheres, which differ in optical properties from the multiphase saliva
particles typically produced by a cough. Only transparent droplets can be measured using
OPC techniques.

2.3.1.4

Aerodynamic particle sizing (APS)

Aerodynamic particle sizing (APS) methods have been used to measure the airborne
diameters of expired particles, meaning that the shape or composition of the particle had
no influence on the measurement (Yang et al. 2007; Morawska et al. 2009; Johnson et al.
2011). The solid or liquid particles passed through a 655 nm laser volume within the APS
unit, and a photodetector generated an electrical signal related to the scattered light. This
technique measured the diameter of particles in the range of 0.3-20 µm with a precision
of 0.02-0.03 µm. APS techniques have been used to investigate the size of airborne
droplets without the use of tracers or dyes. The airflow must be sampled by drawing air
into the measurement unit at a low flow rate (e.g. 5 L/min) (Morawska et al. 2009).

2.3.1.5

Scanning mobility particle spectrometry (SMPS)

Scanning mobility particle spectrometers (SMPS) have been used to detect the smallest
particles (as small as 3 nm) (Rengasamy et al. 2014). An electrostatic classifier is used to
sort particles according to electrical mobility and they are then counted using a
condensation particle counter. SMPS have been used to measure droplet nuclei between
0.02-0.6 µm (Yang et al. 2007). However, with concentrations less than 0.4 particles/cm3,
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long time intervals are required to determine particle distributions as typically less than
4 particles are registered per 2 minutes of activity (Morawska et al. 2009).

2.3.1.6

Laser diffractometry

Zayas et al. (2012) used a He-Ne laser diffractometer in their experiments, to quantify
respiratory aerosols expired during coughing from 26 male and 19 female subjects. A
transmitter and a receiver module created a cylindrical measurement zone of 100 mm
length and 10 mm diameter, with the length perpendicular to the direction of flow.
Participants were asked to cough through this measurement zone (positioned 17 cm away
from the mouth) and the concentrations of particles were sampled at a rate of 2.5 GHz.
Similar to IMI, this technique relied on the scattering of light, under the assumption that
each droplet was a perfect sphere. The angle of diffraction was inversely proportional to
the size of the droplet and the instrument sorted droplets into 60 size bins ranging from
0.1-900 µm. The small measurement volume was a clear limitation to using this method.
It is unlikely that all of the expired droplets passed through the measurement zone, even
if it was positioned directly at the mouth of the participant.
There is currently no method for sizing the entire range of expired particles, without
sampling loss. This has made it impossible to determine the total number of particles and
an accurate size distribution directly at the mouth. Any method which requires particles
to be drawn into a sampling unit, is subject to error due to the amount of travel time.
Particles evaporate before they are measured meaning the diameter has decreased. The
IMI technique used by Chao et al. (2009) and the laser diffractometer used by Zayas et al.
(2012) can measure particles in the airstream, without the need to pump aerosols into a
sampling unit. The IMI technique is the most suitable for determining the expired droplet
distribution at the mouth, since it does not require flow sampling, even though it cannot
measure particles in the submicrometre range.
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2.3.2

Expiratory droplet characteristics

The following section compares the results of several experimental investigations
concerning the droplet distributions of human coughs. Recommendations for modelling
cough droplet dispersion are made based on the values obtained experimentally.

2.3.2.1

Size distribution

Figure 7 compares the average droplet diameters that have been determined
experimentally. The average diameter determined by Duguid (1946), Loudon & Roberts
(1967), and Chao et al. (2009) appear to be in agreement. However, the microscopy and
IMI techniques used were completely insensitive to aerosols smaller than 1-2 µm, which
may have resulted in an overestimate of the actual average expired particle size. In the
experiments of Yang et al. (2007), the samples were bagged, which allowed significant
condensation and droplet settling to occur before analysis. This means that the droplets
are not measured in their expired size, and the water content will accumulate on the walls
of the bag. Papineni & Rosenthal (1997) determined that the average diameter of cough
expired aerosols was 0.7 µm, and that 80-90% of all expired aerosols are smaller than 1
µm. However, the droplets had the opportunity to evaporate substantially before being
measured and the experiments did not detect any particles larger than 2.5 µm. Zayas et
al. (2012) determined that 97% of all expired droplets are smaller than 2 µm, but such
small droplets are expected to evaporate quickly. With all sampling-based approaches
(OPC, APS, SMPS, etc.), the largest droplets are often not measured. Another limitation
arises from the substantial variation in particles observed between different coughs from
the same subject, as well as coughs from different subjects (Zayas et al. 2012).

27

Figure 7: Mean cough droplet diameter with standard deviation (solid horizontal line
indicates lowest measured diameter)

2.3.2.2

Number of particles expired

The experimental results containing the total number of particles expired during a cough
are shown in Table 1, revealing a substantial variation between the different studies. In
addition, not all subjects produced the same number of particles, and participants can be
classified as either low or high emitters (Zayas et al. 2012). To determine an initial particle
distribution produced by coughing, which could be used as boundary conditions in CFD
investigations, measurements must have been taken close to the mouth before
significant water loss has occurred. For this reason, the size distribution (Table 2)
determined by Chao et al. (2009) is probably the most relevant when determining
boundary conditions, even though the IMI technique used could only give a statistical
approximation since sampling losses could not be avoided.
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Table 1: Estimated total number of particles expired per cough
Reference
Duguid (1946)
Louden and Roberts (1967)
Papineni and Rosenthal (1997)
Zhu et al. (2006)
Chao et al. (2009)
Lindsley et al (2015)

Number of particles per cough
2,085
1,085
420
1,850
947-2,085
900-302,200 when subjects were sick,
1,100-308,600 when they had recovered

Table 2: Estimated total expired droplet numbers using size profile at x=10 mm (0.5D)
downstream from the subject (adapted from Chao et al. 2009)
Size range
(µm)
2-4
4-8
8-16
16-24
24-32
32-40
40-50
50-75
75-100
100-125
125-150
150-200
200-250
250-500
500-1000
1000-2000
Total

Duguid (1946)
76
1,041
386
127
47
45
38
38
27
32
30
83
47
40
27
0
2,085

Loudon & Roberts
(1967)
39
542
201
66
25
24
20
20
14
17
16
43
25
21
14
0
1,085

Zhu et al (2006)
67
924
343
113
42
40
34
34
24
29
27
74
42
35
24
0
1,850
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2.3.2.3

Expired droplet concentrations

The experimental investigations have shown that the droplet concentrations vary at
different locations within the cough jet and with respect to the time of sampling. This
means that it was difficult to characterize the droplet concentration and the average
values obtained differ significantly between investigations (Table 3).
Table 3: Average particle concentrations obtained experimentally
Reference
Papineni and Rosenthal (1997)
Yang et al. (2007)
Morawska et al (2009)
Chao et al (2009)

Number of particles/cm3
0.024-0.220
985-2,211
0.64
2.4-5.2

Aerosol dilution before sampling and the inability of the methods used to analyze larger
particles likely contributed to the low concentrations obtained by Papineni & Rosenthal
(1997) and Morawska et al. (2009). The very large concentrations obtained by Yang et al.
(2007) likely occurred because samples were bagged before analysis. Since the overall
concentrations obtained experimentally are influenced by the resolution of the
instrument used and the bin size selected, the concentrations are normalized as
dN/dlog(d), where dN is the particle concentration and d is the bin midpoint particle
diameter. Normalized concentration profiles obtained experimentally are displayed in
Figure 8. Both Loudon & Roberts (1967) and Morawska et al. (2009) data exhibited a
multimodal distribution, with peaks at roughly 1 µm, and 100 µm, and with higher
concentrations reported by Loudon & Roberts (1967). The unique experimental wind
tunnel used by Morawksa et al. (2009), provided what might be a reasonable distribution
of droplet nuclei that have evaporated completely. However, the results have not been
replicated so it is difficult to use these profiles to make conclusions about cough flow
behaviour. The profile obtained by Chao et al. (2009), at a distance of x=10 mm (or
approximately 0.5D), was the most relevent for determining CFD boundary conditions
since no other investigations have examined the size distribution of expired aerosols in
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the region directly adjacent to the mouth, where the majority of the cough jet passes
through the measurement volume. The results obtained by Duguid (1946), appear to be
in agreement with those obtained by Chao et al. (2009). However, Nicas et al. (2005)
explained that the correction factor of 4 for the diameters used by Duguid, was incorrect
and a more reasonable correction factor of 2 would shift the mode of 10 µm, towards
smaller diameters. There is a possibility that expired aerosol concentrations may also be
pathogen dependent and so, again, it is recommended to conduct investigations with
subjects who have contracted the illness.

Figure 8: Normalized experimental droplet diameter concentrations
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2.3.2.4

Droplet dispersion and penetration distance

Based on simulated interrupted jet experiments, the maximum penetration distance,
defined as the farthest location where the jet velocity reduces to 0.01 m/s, was in the
50.6- 85.5 D range (Wei & Li 2017). Based on a coughing mouth diameter of 2 cm, the
maximum penetration distance would be approximately 1.7 m, indicating the potential
for aerosol transport at least up to these distances. The study also observed that the
leading jet vortex plays a significant role in particle transport.
In addition to their PIV experiments, trials were conducted by Zhu et al. (2006), where
flour was expelled by the coughers, and used as a tracer to visualize the dispersion of
saliva droplets expired during a cough. Digital video images of the expired flour showed
the particles traveling at a high speed over the first 30 cm (x=15D) before gradually
dissipating into the surroundings. Some of the flour was found to travel beyond 2 m
(x=100D) so it is expected that droplets or droplet nuclei with a smaller diameter than
that of flour particles, will travel farther.

2.4 Respiratory transmission and viable pathogens in
aerosols
Since the size of an infectious particle is limited by the size of the virus being transported,
it is important to examine the viability of viruses contained within expired aerosols, as
they have the potential to remain suspended for longer periods of time. This means the
recruitment of participants who have been infected with respiratory illnesses is necessary
for droplet studies. To quantify the infectious content, aerosols must be collected, and
the presence of viable virus or bacteria determined biochemically. Evidence that supports
the route of airborne transmission has been determined from the use of mammalian
models (Lowen et al. 2006; Lowen et al. 2009; Mubareka et al. 2009), as well as from the
detection of infectious aerosols within public spaces (Lednicky & Loeb 2013; Yang et al.
2011; Blachere et al. 2009).
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2.4.1

Methodologies

The following section reviews the experimental methods used quantify the presence of
infectious pathogens in droplets and those used to provide evidence supporting the
airborne route of virus transmission.

2.4.1.1

Quantitative reverse transcriptase-polymerase chain
reactions

Quantitative reverse transcriptase—polymerase chain reactions (RT-PCR) are presently
used to detect whether viral RNA is expressed within a sample (Sueki et al. 2016). The
procedure exponentially amplifies the amount of RNA present. However, only the
presence of RNA can be determined, and the viability of collected viruses is not measured.

2.4.1.2

Mammalian models

Due to their susceptibility to infection with human influenza viruses and their ability to
cough and sneeze, the ferret model has been a well investigated animal model for
influenza transmission (Andrews & Glover 1941). However, due to cost and animal
housing concerns, Hartley strain guinea pigs have often been used instead (Lowen et al.
2006; Lowen et al. 2009; Mubareka et al. 2009). Experiments have involved housing
infected guinea pigs with naïve ones, in separate cages, only allowing airflow between the
two groups. However, the guinea pigs do not display any detectable symptoms related to
infection with the disease and so a nasal wash, followed by PCR, determined the presence
of pathogens. Environmental attributes were controlled and altered for experiments, to
determine factors which aid or inhibit transmission. Several methodologies have been
commonly employed in modern experiments.

2.4.1.3

Solid impaction techniques

The use of an Andersen 6 stage cascade impactor has allowed the measurement and
collection of bioaerosols with diameters as small as 0.65 µm (Yang et al. 2011). Viable
bacteria and fungi were collected onto a petri dishes, which made this technique highly
suitable for air quality studies. The sampling stages have up to 400 orifices which draw air
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at a constant flow rate, with each stage having a finer set of nozzles than the previous
one. The technique has been used to evaluate the presence of several bacteria in human
cough airflows either by having subjects cough for 5 minutes through a tube with a
disposable mouthpiece into a 28.3L chamber with 2 Andersen cascade impactors inside
(Fennelly et al. 2004), or by collecting aerosols in a wind tunnel at 1, 2 and 4 m from the
subject’s mouth (Knibbs et al. 2014). Separate trials were conducted by Knibbs et al.
(2014) to assess the duration of aerosol viability. Participants coughed through a snorkel
style mouthpiece into a slowly rotating drum and particles were suspended within the
drum for 5, 15 and 45 min, before they were collected by the impactor.
Another technique that utilizes solid impaction, was developed by the National Institute
for Occupational Safety and Health (NIOSH). The 2-stage cyclone aerosol sampler uses a
portable pump to draw air through two disposable tubes, 15 mL and 1.5mL in volume
(Blachere et al. 2009; Lin et al. 2017). Air is drawn through the first stage where inertia
from the cyclone causes particles to impact on the walls of the centrifuge tube. Particles
with d > 4 µm are collected in the first stage, while the second stage collects particles in
the range of 1 - 4 µm. A final polytetrafluoroethylene (PTFE) filter is typically used to
collect particles with d < 1 µm. PTFE filters have also been used to collect samples directly
with the use of an open-faced filter cassette connected through a tube to a pump (Lin et
al. 2017), or by asking subjects to breathe for 10 mins, read a text for 10 mins, and cough
10 times into a mask with a filter located at the mouth (Steltzer-Braid et al. 2009). This
method is not commonly used because it can cause structural damage to the virus
(Verrault et al. 2008).
A Sioutas personal cascade impactor has also been used to collect particles on PTFE filters
in 5 size ranges including 2.5 - 10, 1 - 2.5, 0.5 - 1, 0.25 - 0.5, and < 0.25 µm (Lednicky &
Loeb 2013). A pump is used to draw air in and particles impact on the surface of the
filters.
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2.4.1.4

Liquid impinging techniques

To avoid some of the limitations of using solid impaction, other studies have collected
aerosols within a liquid collection medium using an SKC BioSampler (McDevitt et al. 2012;
Lednicky & Loeb 2013; Lindsley et al. 2016). The SKC BioSampler has 3 tangential sonic
nozzles that create a swirling flow of the collection medium, when air is drawn through
them. While this minimizes the damage caused to any of the collected agents, it cannot
collect large particles (d > 10-15 µm). The sampler is highly efficient at collecting particles
in the 1-2 µm range, but it is inefficient outside of this range. Since the particle is collected
in a medium, it is impossible to determine its size.
With any impaction method, there is a potential for viable particles to become damaged
upon impact. If the particle survives the initial impact, a constant airstream may destroy
some of the collected pathogens by forcing them through the filter. Despite this, the use
of 0.3 µm PTFE filters has been indicated as the best method for sampling viral particles,
due to the small size of the aerosols in question (Verrault et al. 2008). The selected
sampling method must be able to recover the smallest particles in experiments regarding
human coughs, as these particles have the greatest potential to remain suspended before
they are aspirated.

2.4.2

Viability of aerosol transmission

The following section examines the results of experimental investigations concerning the
viability of airborne transmission.

2.4.2.1

Animal models for virus transmission

Guinea pig experiments have shown that airborne transmission was enhanced at a low
temperature (5 oC) but that a higher temperature (30 oC) interrupted the transmission at
all values of RH. At 20 oC, transmission was highly efficient at an RH of 20 and 35%, low
at 50%, efficient again at 65% and completely absent at 80% (Lowen et al. 2007). The
authors tentatively attributed the effect of low temperature to the increased viral load
observed in the animals at this temperature, but they proposed no explanation for the
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effect of high temperature. Interestingly, this did not interfere with contact transmission
between animals in the same cage (Lowen et al. 2008). As the authors noted, the effect
of RH is indicative of the decay in infectivity of influenza virus aerosols.
In another study, the same group again used the guinea pig model to show stronger
experimental evidence for aerosol transmission by documenting instances of
transmission between the cage of the animal located above the source animals’ cage, at
a separation distance of 80 or 107 cm (Mubareka et al. 2009). Another important
observation was that different influenza strains varied considerably in their capacity for
aerosol transmission. While animal models are useful for examining external influences
on transmission, it is necessary to examine the human expiration of viral aerosols and the
potential for inspiration of such particles.

2.4.2.2

Viable virus aerosols in public spaces

There is also substantial evidence that viable viruses are shed through expiratory events.
Aerosols have been collected from the apartment of two occupants who were infected
with influenza (Lednicky & Loeb 2013). The samplers were positioned beneath ceiling
vents to sample at locations with airflow. The results suggested that the ultrafine aerosol
particles produced by people who are ill contain viable virus. Most viable virions were
collected in the 0.25 - 0.5 µm range.
The concentration and size distribution of droplet nuclei of influenza viruses were
measured during the 2009 - 2010 flu season (Yang et al. 2011). Nine samples were
collected from a health centre, 4 from a day care facility, and 3 from aeroplanes. Eight
aerosol samples contained influenza A virus, with the concentration ranging from 5800 to
37000 genome copies per m3. On average, 64% of virus-laden particles were found to be
smaller than 2.5 µm.
NIOSH 2-stage samplers were used to collect aerosols in the waiting room and
examination rooms of the emergency department in a hospital (Blachere et al. 2009).
Seventy-four stationary samplers were used for 4-5 hrs, along with 7 personal samplers
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worn by physicians for 3-4 hrs. PCR results showed that 46% of the influenza particles
were found in the first stage of the samplers, (d > 4 µm), 49% in the second stage (1-4
µm), and 4% on the backup filter (d < 1 µm). The findings of the study quantitatively
support the possibility of airborne virus transmission, with 53% of detected virus particles
in the respirable fraction.

2.4.2.3

Viability of pathogens in cough generated aerosols

Experiments have been conducted to determine the concentrations and size distribution
of cough aerosols containing Mycobacterium tuberculosis (Fennelly et al. 2004). Viable
aerosols were detected in coughs from 4 participants and 90% of viable units were
between 0.65-3.3 µm. One significant limitation was referral bias, since most subjects had
multi-drug resistant tuberculosis and the researchers only recruited subjects undergoing
treatment.
In 16 of 18 experiments with cystic fibrosis patients, viable Pseudomonas aeruginosa was
collected at all distances (1, 2, and 4 m) (Knibbs et al. 2014). In the duration experiments,
viable pathogens were collected after 45 min for 14 of 18 subjects. Most viable particles
were smaller than 3.3 µm, indicating their ability to remain aerosolized for longer periods
and over longer distances. In experiments that recruited influenza patients, 25 of 50
expired aerosol filter samples tested positive for respiratory viruses using PCR (SteltzerBraid et al. 2009). Viruses were detected in the aerosols from 12 subjects in breathing
trials, 9 while talking and 2 from coughing. However, the researchers indicated that the
majority of the study population had mild infections, or they may have passed the peak
of shedding. Lindsley et al. (2016) attempted to avoid such issues by conducting their
experiments with patients who were typically exhibiting symptoms for two days prior to
recruitment. Fifty-three of 63 subjects tested positive for influenza A. From these 53,
viable influenza was detected in the cough aerosols of 28 subjects and in the exhaled
breath of 22 subjects.
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Since bacteria are substantially larger than viruses, it is possible that viable viruses can
travel as far or potentially further than the 1, 2 or 4 m distance investigated (Knibbs et al.
2014). Although, it has been indicated that a loss of water content can cause the
inactivation of viruses (Aliabadi et al. 2011), recent investigations have disputed this claim
(Kormuth et al. 2018). Experiments concerning the influenza virus have been primarily
conducted directly at the mouth and, since larger separation distances are common for
interpersonal interactions, the exposure to viruses at such distances must be measured
and quantified. It is necessary to determine the amount and size of viable viral aerosols
produced during an expiratory event for the development of a predictive model, but the
limitations of the available methods presently prevent the reliable determination of such
distributions.

2.5 Conclusions and recommendations
The path of an aerosolized particle begins with its introduction into the environment via
an expiratory event such as a cough, but there are several gaps in the current state of
knowledge on airborne respiratory virus transmission. In general, a large variation exists
in the values achieved for peak flow rates, velocities and expired volumes between and
within studies. There is a lack of a predictive model for such flows due to the small cohorts
of recruited participants and due to the limitations of the available experimental
methods. There is also a lack of evidence demonstrating similarities or differences in
cough airflows and particle distributions between sick and healthy subjects. Furthermore,
there is no evidence indicating a statistically significant difference in coughs between
male and female participants.
Several investigations have examined the fluid mechanics of cough flow behaviour in the
region near the mouth, while only one study looked at the flow further downstream. To
address the gaps identified previously, it is recommended that experiments are
conducted to map cough flow at greater distances from the mouth. Experiments must be
conducted with subjects who have been naturally infected with influenza, as well as
healthy control subjects. Air sampling of expiratory aerosols is also necessary to
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determine the viability of expired pathogens, and a large cohort must be recruited to
make statistically significant predictions regarding airborne virus transmission. Due to its
accuracy and ability to resolve velocity fields spatially, particle image velocimetry (PIV)
was determined to be a very suitable method of examining airflows. However, seeding of
the flow field with particles that have a low settling velocity is required. It is difficult to
distinguish between particles produced by coughing, and those used to seed the flow in
the experiments, so droplet sizing and biological sampling cannot be conducted in the
same trials as airflow measurements.
After evaluating the experimental results and methodologies, several conclusions can be
drawn from the present review. It is our assessment that based on the variability you
would notice an average peak flow rate of approximately 7.0 L/s. Based on a measured
mouth opening area of 4.0 cm2, a peak velocity of 17.5 m/s at the mouth is reasonable to
use in any physical or computational model and a jet spread angle of around 25° is
expected. When determining the number of particles to use for a cough model,
advancement of knowledge was inhibited by the inability to reliably measure the particle
distributions. It is proposed that a reasonable distribution to use in a cough model is that
provided by Chao et al. (2009) (Table 2), even though the smallest particles were not
measured. Since the largest droplets contain most of the liquid volume of the cough, it
was expected that those droplets contain the greatest concentrations of a virus.
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Chapter 3

3

Experimental measurements of far-field human cough
airflow

3.1 Introduction
Communicable respiratory diseases have demonstrated the potential to cause global
pandemics, which has resulted in increased economic expenditures, and many deaths
worldwide (de Francisco et al. 2015; Lafond et al. 2016). The significance of the airborne
route of virus transmission has been a topic of recent interest in the healthcare
community.
Respiratory activities, such as coughing, sneezing, breathing and talking, generate and
disperse pathogen bearing aerosols (Morawska 2006). The distance that these particles
travel depends on both the size of the particle and the velocity at which it is expired (Xie
et al. 2007). Recent reviews supported the claim that droplet nuclei smaller than 5 μm
behave much like a gas and are capable of remaining suspended within the air for long
periods of time (Tellier 2009; Ai & Melikov 2018).
Several studies have tried to determine the size distribution of aerosolized particles
produced by coughing, but the distributions varied between experiments (Yang et al.
2007; Xie et al. 2009; Morawska et al. 2009; Johnson et al. 2011; Zayas et al. 2012). It has
been indicated that 99% of all expired particles are smaller than 10 μm and they can be
easily inhaled by a susceptible host. By taking measurements of particles in their
equilibrium states (after all volatile water content has evaporated), a multi-modal
distribution of particle sizes with peaks at 1 μm and 100 μm, has been observed
(Morawska et al. 2009; Johnson et al. 2011). Biological sampling has confirmed the
presence of viable pathogens within these aerosols (Steltzer-Braid et al. 2009; Lindsley et
al. 2010; Lindsley et al 2016). Experimental investigations concerning subjects who have
been naturally infected with influenza have shown that 65% of influenza RNA was found
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in particles smaller than 4 μm, although the presence of influenza RNA does not
necessarily indicate the presence of viable viruses (Lindsley et al. 2010).
The velocity at which infectious particles are introduced into the environment influences
the potential for transmission. Several investigations have been conducted to examine
the flow behaviour of coughs at or near the mouth of human subjects (Mahajan et al.
1994; Afshari et al. 2002; Zhu et al. 2006; Chao et al. 2009; Gupta et al 2009; Tang et al.
2009; VanSciver et al. 2011; Nishimura et al. 2013; Bourouiba et al. 2014), but only one
investigation has ever examined cough flow behaviour beyond this region (Savory et al.
2014). While determining the cough flow behaviour close to the mouth can be useful for
determining boundary conditions for numerical or physical simulations, the flow
behaviour in the far-field is more important when assessing the potential for virus
transmission, since such separation distances are more common for most human
interactions. Volumetric flow rates, volumes and peak velocity times of coughs have been
determined using spirometry techniques (Mahajan et al. 1994; Gupta et al 2009), whereas
shadowgraph techniques (Tang et al. 2009), video imaging (Nishimura et al. 2013;
Bourouiba et al. 2014), and particle image velocimetry (PIV) (Afshari et al. 2002; Zhu et al.
2006; Chao et al. 2009; VanSciver et al. 2011; Savory et al. 2014), have been used to
visualize the flow field. The experimental results vary significantly between experiments
and between subjects, and no well-defined model exists for near-field or far-field cough
behaviour. Furthermore, the separation distance distinguishing between the near-field
and far-field of cough flow behaviour has not been defined. All previous investigations of
the flow field have been conducted with healthy subjects, and so there is no evidence
indicating that coughs from subjects who have been naturally infected with respiratory
viruses behave like those from healthy subjects. Statistical issues also become evident,
due to the small number of subjects recruited for the experiments.
Very little is known about the production and dispersion of viral bioaerosols, even though
such information is critical in healthcare settings during viral outbreaks. Viable influenza
particles have been recovered through air sampling at hospitals, health centres and on
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airplanes (Booth et al. 2005; Blachere et al. 2009; Yang et al. 2011) and several factors
have been shown to influence airborne transmission of the influenza virus. Guinea pig
models have demonstrated that low relative humidity (RH) and low temperatures
enhanced the transmission of the influenza virus whereas high RH and high temperatures
interrupted transmission (Lowen et al. 2007; Lowen et al. 2008; Steel et al. 2009;
Mubareka et al. 2009). Despite this, there is a widespread adoption of the “3 ft/1 m” and
6 ft/2 m rule” (Deller et al. 2008; Kennamer et al. 2007), which has considered such
separation distances from patients infected with respiratory viruses to be safe, without
any evidence to support the claim.
The objective of the present investigation is to rigorously test the “3 ft/1 m rule,” by
conducting velocity measurements and bioaerosol sampling at 1.0 m from the mouth of
human subjects. Based on an average mouth opening diameter of D=0.02 cm (Gupta et
al. 2009), this region is calculated to be approximately x=50D. Experiments were
conducted to map the flow field of human coughs at greater distances than those studied
previously and to develop a model for transient cough jet behaviour. Subjects who have
been naturally infected with influenza participated in experiments while they were sick
and again when they had recovered. A cohort of healthy volunteers was recruited as a
reference to assess any difference in the aerodynamic behaviour of coughs from the two
groups. The velocity measurements were also used to validate computational fluid
dynamics (CFD) models based on unsteady Reynolds-averaged Navier-Stokes (URANS)
and large eddy simulation (LES) methods developed by Bi (2018).

3.2 Methodology
The following section details the methods used in the experimental investigation.

3.2.1

Experimental facility and procedure

The experimental chamber (Savory et al. 2014), consisted of a 1.81 m x 1.81 m x 1.78 m
enclosure, with all interior surfaces painted black, except for a glass window allowing
optical access (Figure 9). The dimensions of the chamber were selected so that the cough
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airflow was not noticeably influenced by the chamber walls. A pear-shaped opening, with
a padded head rest and chin rest, fixed the participant’s head in place, but allowed the
participant to cough into the chamber with their nose and mouth unobstructed. Subjects
were asked to cough 3 times each for individual trials in separate particle image
velocimetry (PIV) and hot-wire anemometry (HWA) experiments with aerosol sampling.
Participants waited for approximately 2 min between coughs to minimize the residual air
motion within the chamber.

Tube for seeding particles
Settling chamber

CCD PIV Camera

532 nm Nd:YAG laser
Mirror assembly

Figure 9: Schematic diagram of experimental facility and PIV apparatus
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3.2.2

Particle image velocimetry (PIV)

PIV has commonly been used as a non-intrusive, technique to measure airflow fields due
to its accuracy and spatial resolution. For PIV experiments, the chamber was seeded with
aerosolized Titanium Dioxide (TiO2) particles (ranging between 0.15 to 0.47 µm with 69%
of particles between 0.34-0.43 µm) that were dried in a vacuum oven. The particles were
stored in a drum which was placed on top of a loudspeaker that vibrated to aerosolize the
powder. The seeding particles were carried into the chamber from the drum by a 30 kPa
air-line. Particles were illuminated by a 120 mJ per pulse, 532 nm Nd:YAG laser, which
was directed through an angled mirror and a cylindrical/spherical lens assembly to create
a laser sheet (~1 mm thickness). Each pulse has a duration of 3-5 ns, and synchronized
image pairs were recorded by a CCD camera at a frequency of 15 Hz (2018 experiments)
and 16.7 Hz (2014 experiments, Savory et al. 2014). An image separation time of Δt=100
µs was used, and laser pulse delay and PIV exposure times of 400 µs and 405 µs were
selected, respectively.
In the experiments conducted in 2014, much of the cough flow missed the small field of
view in some trials, and many coughs missed completely. To contain the entire width of
the cough within the imaged window and due to a necessary change in the camera used,
a new field of view was selected for the experiments conducted in 2018 (Figure 10). Both
windows were centred at x=1 m downstream from the participant and they were
translated downward to compensate for the typically downward initial cough trajectory
(Gupta et al. 2009). A recursive Nyquist cross-correlation algorithm was used, in TSI
Insight 4G software, to process images into velocity vector arrays. A final spot dimension
of 32 x 32 pixels was used for the 2014 images, whereas it was increased to 64 x 64 pixels
to compensate for the decrease in spatial resolution from 10.0 pixels/mm to 6.87
pixels/mm. Since the camera is farther from the laser sheet, increasing the field of view,
a larger final spot dimension is necessary to ensure the proportion of validated vectors is
over 85%. Eighty image pairs are recorded for each cough, allowing enough time for the
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cough to pass the field of view completely. The time at which the cough is first visible in
the field of view was set to be t=0.0 s in all further data analysis.

Figure 10: PIV field of view on cough chamber centre plane
Time histories for the 2D velocity magnitude, V, were computed according to Equation
3.1.
𝑉 = √𝑢2 + 𝑣 2

(3.1)

where: u is the streamwise velocity component in the x-direction, v is the vertical
component in the y-direction
The time histories were extracted at the cough jet centre as well as at the chamber centreline and the HWA location, x = 1 m away from the subject. The cough jet centre was
defined as the mid-point of the cough, where the greatest velocities are present, after
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examining the velocity contours and vector arrays (typical cough shown in Figure 11). If
no clear jet centre was evident, the cough was not used for analysis. Coughs were
excluded from the analysis if, at each extraction location, the peak velocity was below
0.20 m/s, because low velocities made it impossible to distinguish the jet boundaries and
locations required for this analysis. The peak velocity was calculated after subtracting the
residual air motion present within the chamber prior to the arrival of the cough. This
quantity was usually measured to be approximately 0.05 m/s.

Figure 11: Instantaneous 2D velocity magnitude contour with overlaid vector arrows
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Figure 12 displays an example of an instantaneous velocity time history. For further
comparison, the cough jet centre velocity magnitude profiles were normalized according
to Equation 3.2. Time was normalized by a similar method according to Equation 3.3.

Figure 12: Example instantaneous velocity time history at cough jet centre with key
quantities labeled
𝑉(𝑡)−𝑉𝑠

𝑉𝑛𝑜𝑟𝑚 = 𝑉

𝑝𝑒𝑎𝑘 −𝑉𝑠

(3.2)

where: Vs is the residual velocity within the chamber at t=0, Vpeak is the maximum
velocity at the peak of the cough
𝜏=𝑡

𝑡

𝑝𝑒𝑎𝑘

where: tpeak is the time at which Vpeak is observed.

(3.3)
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3.2.3

Hot-wire anemometry (HWA)

HWA was used to measure the instantaneous velocity magnitude at single location. A
constant temperature anemometry (CTA) unit was attached to a probe containing a
tungsten wire 1.25 mm long and 5 µm in diameter), and voltage readings are recorded at
a rate of 1 kHz. The system was calibrated for low airflow speeds using a specialized facility
detailed in Mohamed (2017). The sensor was located x=1.00 m downstream from the
mouth of the participant, y= -0.17 m below the inlet centre-line, since preliminary trials
had indicated that the cough jet travelled along a slight downward trajectory. A moving
average filter was applied to the measurements to filter out high frequency fluctuations
and noise. The size of the averaging window was selected such that further increasing the
window size does not substantially alter the root mean square of velocity fluctuations
about the moving average. The HWA velocity time histories were normalized by the same
method described earlier.

3.2.4

Computational fluid dynamics (CFD)

Two separate CFD models have been previously developed, based on LES and URANS
methods (Bi 2018), in which the boundary conditions were selected based on the average
volumetric flow rate profiles and mouth opening diameters determined experimentally
by (Gupta et al. 2009). The inlet velocity was specified to match the velocity shown in
Figure 13, and a mouth diameter of D=0.0217 m was used for the simulation. The LES data
was filtered using the same moving averaged method utilized to smooth the HWA data.
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Figure 13: Cough inlet velocity time history (CFD)

3.2.5

Biological sampling (“Sick” participants only)

To assess the presence of viral pathogens within the cough airflow, 2
polytetrafluoroethylene (PTFE) membrane filter cassettes (1 µm pore size) were attached
to low-flow (4000 ± 40 mL/min) sampling pumps (SKC Inc., Airchek 224-PCXR3). The filter
cassettes were suspended within the chamber at distances of 0.5 m and 1.0 m from the
mouth of the subject, along the chamber centreline. Air sampling was performed
concurrently with the HWA measurements and the pumps drew air onto the filters for a
period of 15 minutes after the 3 coughs were performed. A mid-turbinate swab specimen
was also self-collected immediately prior to the experiments to identify and verify the
illness experienced by a subject. The filters and MTS were shaken for 10 s within a vial of
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UTM viral transport medium by a vortex shaker. The vials were stored at -80°C in a freezer
until they were shipped, on dry-ice, for analysis at Sunnybrook Health Sciences Centre
and Research Institute: University of Toronto by the Department of Microbiology, Division
of Infectious Diseases. The identity of all pathogens was determined by a multiplex
polymerase chain reaction (multiplex-PCR) from a panel of respiratory viruses. Biological
sampling was not performed during “convalescent” trials, or throughout experiments
with the group of “healthy” control subjects.

3.2.6

Participant recruitment

The recruitment procedures were approved by Western’s Research Ethics Board (REB
approval no. 108945). Subjects with influenza-like illnesses were referred to the study
after making an appointment to see a physician at Western Student Health Services.
Following referral, subjects completed a questionnaire to determine if they were eligible
to participate in experiments. Participants needed to be between 18-35 years of age, and,
in the last 24 hours, they should have experienced a fever and cough/sore throat in the
absence of any other known cause of illness (e.g. allergies).

Anyone who was

immunocompromised, had underlying cardiopulmonary conditions, was pregnant, or
smoked was excluded from the study. Presumably-ill subjects were recruited during the
flu seasons of 2013-14, 2016-17 and 2017-18. Measurements were recorded for “sick”
trials, while the subjects are ill, and, when they had recovered, the subjects return for a
set of “convalescent” experiments. Healthy control subjects were recruited outside of the
flu season.

3.3 Results and discussion
Throughout the duration of the investigation, 77 sets of experiments were conducted for
58 different subjects. Table 4 summarizes the number of measurements taken for each
method. In the 2014 investigation, the HWA probe was only used as a reference, and it
was not calibrated. PIV data were not available during the 2017 study period.
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Table 4: Total number of samples across all cohorts
Date

Cohort

201718

Sick
Convalescent
Healthy
Sick
Convalescent
Sick
Convalescent
Healthy

201617
201314
Totals

Number
of
subjects
7
7
25
9
9
5
3
12
77*

Coughs
sampled
(PIV)
21
21
75
15
9
36
177

Coughs
sampled
(HWA)
21
21
75
27
24
171

Filter
Cassette
Samples
14
18
10
42

MTS Samples

7
9
5
21

*77 sets of experiments from 58 different subjects

3.3.1

Biological samples (Filter cassettes and MTS)

Table 5 summarizes the MTS results obtained throughout the investigation. Overall, the
percentage of subjects with a confirmed respiratory virus (57%) was very good
considering the recruitment methods. A recruitment strategy based on self-referral may
have resulted in an increased number of subjects, but it is expected that such a strategy
will result in a much greater proportion of negative results. While several investigations
have demonstrated the presence of viral particles within the cough aerosols of human
subjects (Steltzer-Braid et al. 2009; Lindsley et al. 2010; Lindsley et al 2016), no viral RNA
was detected on any of the PTFE filters. It is possible that the virus-containing aerosols
were directed past the sampling locations due to the strength and angle of the cough.
Another important reason is that the total volume of liquid expelled as droplets was very
low. Since the sampling method relied on the inertial impaction of aerosolized particles
onto the filter surface, only the smallest particles could be collected. With solid impaction
techniques, there is also a possibility that a virus could be destroyed upon contact with
the membrane surface (Verrault et al. 2008).
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Table 5: MTS results
Date

Number of
subjects

2018

7

2017

9

2014

5

Totals

21

3.3.2

Recovered pathogens
Pathogen
Subjects
Influenza B
Adenovirus
Coronavirus NL63
Influenza A, H3N2
Coronavirus NL63
Coronavirus OC43
Respiratory syncytial virus
Influenza A, H1N1
Coronavirus NL63
Respiratory syncytial virus
-

3
1
1
1
1
1
1
1
1
1
-

5

Recruited
subjects with
verified illness
71%

4

44%

3

60%

12

57%

Total

Cough direction and spread angles

The average location of the cough centre at x=1.0 m, was at y=-0.122 m (below the cough
inlet centerline, or 0.548 m above the chamber floor). The total range of cough exit angles
measured was between 3° (above the centre-line) to 15° (below the centreline), and an
average downward angle of θc=7° was observed. Previously, cough angles have been
defined at the mouth by two downward jet angles: θ1=15 ±5 ͦ and θ2=40 ±4 ͦ (Figure 14)
(Gupta et al. 2009). The average cough exit angle from the literature, determined by the
midpoint between θ1 and θ2, was 27.5° below the horizontal, indicating that the head and
chin rests used in the investigation adequately reduced this angle so that the cough could
be measured at the desired location. The jet spread angle, θ, was calculated from the
maximum measured width of the jet at x=1.0 m. The upper and lower jet boundaries were
selected to be the location at which the velocity fell below 0.05 m/s. An average spread
angle of θ=24° (Min. = 15°, Max. = 27°, Std. dev. = 3°) was measured, which is consistent
with the spread angles previously determined (Tang et al. 2009; Gupta et al. 2009).
Through a critical review and analysis of experimental and numerical investigations, Ball
et al. (2012) determined that steady free jets also exhibited spreading angles between 2035°, which was consistent with the findings of the present investigation.
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θc

1.0 m

Figure 14: Cough jet angles, θ1=15 ± 5 ͦ, θ2=40 ± 4 ͦ, θ=25 ± 9 ͦ, (adapted from Gupta et
al. 2009)

3.3.3

Cough velocity

The peak velocity magnitude, Vpeak, was used to characterize the strength of cough flow
behaviour in the far field. A comparison of the strengths of coughs from different cohorts
is displayed in Table 6. As expected, the greatest average velocities were noticed at the
cough centre, followed by the HWA location. The fewest number of coughs were used for
the velocity analysis at the centreline location. Very often, the cough missed this location
entirely, or the peak velocity at the location was below 0.20 m/s. Also, the profiles often
would not resemble the characteristic cough jets examined here, and only strong
fluctuations were observed in the excluded profiles.
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Table 6: Average peak 2D velocity magnitude point extractions (PIV)
Extraction Location

Date

Cohort

Apparent cough jet 2017Sick
centre (PIV),
18
Convalescent
(x=1.00 m, y=-0.12 m)
Healthy
(average location)
2013Sick
14
Convalescent
Healthy
Hot-wire location
2017Sick
(PIV),
18
Convalescent
(x=1.00 m, y=-0.17 m)
Healthy
2013Sick
14
Convalescent
Healthy
Cough chamber inlet 2017Sick
centreline (PIV),
18
Convalescent
(x=1.00 m, y=0.00m)
Healthy
2013Sick
14
Convalescent
Healthy
Hot-wire
2017Sick
anemometer (HWA),
18
Convalescent
(x=1.00 m, y=-0.17 m)
Healthy
2016Sick
17
Convalescent

Coughs
used for
analysis

Average Vpeak
(m/s) by
cohort

Average
Vpeak (m/s)
at location

13
19
66
9
4
15
14
20
69
10
4
21
2
5
14
11
4
17
20
13
68
18
15

1.34
1.03
1.19
0.75
0.65
0.91
1.03
0.93
1.03
0.68
0.59
0.90
0.83
0.90
0.77
0.62
0.47
0.72
0.78
0.86
0.75
0.88
1.01

1.17

Coughs
used for
analysis per
location
126

0.92

138

0.71

53

0.82

134

A t-test with a significance level of α =0.05 did not show a statistically significant
difference in the peak cough velocity magnitude, Vpeak, between each cohort. Similar
values were noticed for the average peak velocities noticed at the cough centre, HWA
location and along the inlet centreline (Tables 7-10) between cohorts, so it is expected
that if more participants were recruited, and a greater number of coughs were analyzed,
the average peak values would converge. Table 11 shows the resulting p values obtained
for the comparisons between the sick cohort and the healthy group, convalescent group,
and a group containing both. These values represent the probability that the average
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Vpeak, is the same between the groups indicated for each comparison. The obtained values
are very high compared to the significance level. This indicated a strong possibility that
the differences between the groups were obtained due to chance rather than a true
difference in the strengths of cough between groups.
Table 7: Average peak velocities at cough centre (PIV)
Cohort

Average Vpeak (m/s)

Standard Deviation (m/s)

Sick
Convalescent
Healthy
All

1.09
1.01
1.22
1.17

0.44
0.48
0.55
0.52

Number of
coughs
22
23
81
126

Table 8: Average peak velocities at HWA location (PIV)
Cohort

Average Vpeak (m/s)

Standard Deviation (m/s)

Sick
Convalescent
Healthy
All

0.85
0.82
0.96
0.92

0.40
0.47
0.51
0.49

Number of
coughs
24
24
90
138

Table 9: Average peak velocities at cough inlet centerline (PIV)
Cohort

Average Vpeak (m/s)

Standard Deviation (m/s)

Sick
Convalescent
Healthy
All

0.65
0.71
0.74
0.71

0.40
0.33
0.39
0.37

Number of
coughs
13
9
31
53

Table 10: Average peak velocities (HWA)
Cohort

Average Vpeak (m/s)

Sick
Convalescent
Healthy
All

0.84
0.98
0.75
0.82

Standard Deviation
(m/s)
0.49
0.59
0.42
0.49

Number of
coughs
38
28
68
134
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Table 11: p-values calculated for comparison of mean velocities
Sampling location
(Method)
Cough jet centre (PIV)
HWA location (PIV)
Inlet centreline (PIV)
HWA location (HWA)

p value for comparison between sick cohort and group indicated
Convalescent
Healthy
Conv + Healthy
0.56
0.81
0.71
0.2968

0.31
0.33
0.49
0.3215

0.50
0.46
0.50
0.2721

The peak velocities recorded by the HWA and averaged for each group (Table 9) were
comparable to those measured by PIV at the HWA location (Table 7). An average value of
0.82 m/s was measured by the HWA, whereas 0.92 m/s (11.5% difference) was measured
using PIV.
The normalized profiles were plotted for the sick, convalescent and healthy groups, and
an average curve was obtained for each. These averages were plotted together (Figure
15), and the similarity in coughs between cohorts was further observed. A rapid increase
in velocity up to the peak value is observed, followed by a quick decay of velocity in the
region of 1 < τ < 3, and ending with a gradually decreasing tail.
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Figure 15: Mathematical modeling of average normalized time histories at cough centre
(x=1.0 m)
The overall average curve representing all the cohorts can be used to develop a simple
mathematical model for the normalized velocity profile, as described by the formulae in
Equation 3.4 and shown in Figure 10. These formulae may be used to approximate the
centreline velocity of a cough jet at x= 50D. The applications of such a model are in the
development of computational cough and transient jet simulations, or in the validation
of coughs produced by physical simulations.

𝑉𝑓𝑖𝑡 (𝜏) = {

𝜏 2.884 , 0 ≤ 𝜏 ≤ 1
0.5

,
𝜏−0.5

1<𝜏

(3.4)

To better understand the relationship between the peak velocity and the time at which it
occurs, the two quantities were plotted in Figure 16, and a reciprocal fitting curve was

66

obtained (Equation 3.5). Although there is scatter in the data, by using Equations 3.2-3.5,
the centreline velocity time histories at x= 50D, can be developed based on any specified
peak velocity. A user chooses a value Vpeak, which allows for τ to be computed so that
Equation 3.4.
𝑉𝑝𝑒𝑎𝑘 = 𝑡

𝑘

𝑝𝑒𝑎𝑘

(3.5)

Where k is the average distance between the front of the jet and the point at which the
maximum velocity occurs (k=0.55 m) The k values computed for all cohorts and methods
were similar (k=0.62 m for HWA, k=0.55 m for cough jet centre (PIV), k=0.53 m for HWA
location (PIV), k=0.39 m for centerline (PIV), k=0.33 m for LES, k=0.43 m for URANS).

Figure 16: Variation of peak velocity with time of peak at cough centre (x=1.0 m, y
location varies)
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3.3.4

Turbulence characteristics

The fluctuations about the moving average of the HWA signal was used to characterize
the turbulence present at the peak of the cough. The normalized power spectral density
(PSD) was used to indicate the distribution of energy within turbulent eddies of variable
size. Figure 17 displays the normalized power spectral densities for coughs from 6
example coughs from different participants (2 from each cohort, randomly selected). A
slope of -5/3 was observed between 8-100 Hz, which is consistent with the Kolmogorov
decay law, and only subtle differences are observed between coughs. The turbulence
intensity was estimated from Equation 3.6 (Iua) and from integrating the area under the
PSD curve (Ius).
𝐼𝑢𝑎 = 𝑉

𝑉′𝑟𝑚𝑠

𝑝𝑒𝑎𝑘 −𝑉𝑠

where: V’rms is the root mean square of velocity fluctuations

Figure 17: Normalized PSD of velocity fluctuations

(3.6)
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Overall, the turbulence intensities computed using both methods were very similar. Table
12 shows the average turbulence intensities calculated for all coughs.
Table 12: Comparison of average turbulence intensities obtained from each method
Quantity

Iua (%) (from moving average)

Ius (%) (from spectrum)

Average
Std. Dev.

8.9
3.9

6.9
2.4

There are several factors that must be considered as limitations to the present work. It is
possible that the type of viral infection will influence the production of mucous within the
lungs and may alter the way a person will cough, such that it may not be accurate to treat
all respiratory viruses the same. It is also assumed that the trajectory of a natural cough
may be different from those studied here since the motion of the head is restricted in the
trials. It is also assumed for this investigation that a forced cough will behave
aerodynamically like a naturally occurring cough.

3.3.5

Computational fluid dynamics (CFD) model comparison and
analysis

The validity of the numerical simulation was determined by comparing the normalized
experimental velocity profiles with those determined computationally (Figure 18). A peak
velocity of 0.83 m/s is obtained from the URANS simulation, whereas it is higher in the
LES with a value of 1.07 m/s. The peak velocity observed in the LES was closer to the
average value obtained from PIV experiments (1.17 m/s) for which there was no
prescribed inlet velocity. This slight difference was expected, since in the analysis of
experimental data, coughs with very low velocities were excluded, whereas the average
value determined by Gupta et al. (2009) included the lowest velocity coughs as well.
Despite this, both the URANS and LES showed good agreement with the experimental
results. The LES may have been a better representation of a realistic cough, but it was
substantially more computationally expensive and so may not be practical for some
investigations.
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Figure 18: Normalized velocity profiles (CFD) compared to average PIV data at x=1.0
m, on cough jet centerline (y=z=0)
To gain a better understanding of the decay in Vpeak with respect to distance from the
source, the instantaneous velocity time histories were extracted along the simulated
cough centreline every 0.1 m, starting at the inlet and extending to x=1.5 m. The
normalized peak velocity, Vpeak-n, was calculated according to Equation 3.7, and it was
plotted with the distance from the inlet (Figure 19).
𝑉𝑝𝑒𝑎𝑘−𝑛 =

𝑉𝑝𝑒𝑎𝑘
𝑉𝑖𝑛𝑙𝑒𝑡

(3.7)

where: Vpeak is the peak velocity magnitude observed at each location, Vinlet is the peak
velocity magnitude observed at the inlet
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As examined by Bi (2018), the width of both steady and transient jets increases linearly
from the virtual origin, x0. The cross-sectional area of the jet is therefore proportional to
(x- x0)2 so a fitting curve that could be used to predict the decay of the peak velocity
observed downstream was determined (Equation 3.8). This relationship was based on the
LES simulation since it provides a better approximation of real flow behaviour.
0.085

𝑉𝑝𝑒𝑎𝑘−𝑓𝑖𝑡 (𝑥) = (𝑥+0.154)2

(3.8)

Figure 19: Variation of normalized peak velocity and distance from the inlet (CFD)
By examining Figure 19, the far field was estimated as the approximate region where x >
0.15 m. If the velocity time histories at each location are normalized by their respective
peak and time that the peak occurs, the validity of this boundary distance is confirmed
for the simulated jets examined here. Figure 20 and Figure 21 show that the two
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normalized velocity profiles in the region x ≤ 0.15 m demonstrate a poor agreement with
the experimental cough centre profile at x=1.0 m, for both URANS and LES simulations.

Figure 20: Normalized velocity magnitude time histories for x=0.0-0.1 m, on cough jet
centerline (y=z=0) (LES and average PIV)
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Figure 21: Normalized velocity magnitude time histories at x=0.0-0.1 m, on cough jet
centerline (y=z=0) (URANS and average PIV)
However, a good agreement is noticed in the normalized profiles at distances of x ≥ 0.15
m for the LES data only (Figure 22). Each of the LES velocity time histories oscillates around
the average experimental profile. The URANS method overestimates Vnorm at all locations
when τ > 1 (Figure 23). It may be considered that the present model for far-field cough
flow is valid in the region x ≥ 7 D, based on an estimated mouth opening diameter of
0.0217 m (Gupta et al. 2009). By combining numerical and experimental results, the
model can be conservatively applied to approximate the cough jet behaviour at any
location in the far field, although measurements of actual cough flow fields at greater
distances than x = 1.0 m is recommended to confirm the validity.
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Figure 22: Normalized velocity magnitude time histories at x=0.2-1.5 m, on cough jet
centerline (y=z=0) (LES and average PIV)
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Figure 23: Normalized velocity magnitude time histories at x=0.2-1.5 m, on cough jet
centerline (y=z=0) (URANS and average PIV)

3.4 Conclusions
The objectives of the present investigation were to rigorously test the “3 feet” or “1
metre” rule as a supposed safe separation distance from a coughing person, as well as to
develop an experimental model for human cough flow behaviour. This model was used
to validate a computational fluid dynamics (CFD) model based on unsteady Reynoldsaveraged Navier-Stokes (URANS) and large eddy simulation (LES) methods (Bi 2018).
Throughout the study period, a total of 77 experiments were conducted from 58 different
subjects. From these subjects, 21 presented with influenza like illness. Of these 21, 12

75

subjects had laboratory confirmed respiratory infections, which was a good result given
the recruitment methods. In the experiments, 177 coughs were measured using particle
image velocimetry (PIV), 171 using hot-wire anemometry (HWA) and 63 were sampled
with polytetrafluoroethylene (PTFE) filter cassettes.
By combining the experimental measurements and data obtained from previous CFD
simulations, a complete model for cough centreline velocity behaviour has been
developed. Although a high degree of variability is observed between individual coughs,
the average profiles are a good representation of the expiratory airflow field produced by
a human cough in the region x ≥ 12 D. This approximate location can be used to distinguish
between near-field and far-field cough jet behaviour. An average peak velocity of 1.17
m/s was observed at the cough centre, 1.0 m downstream, which is comparable to the
1.07 m/s velocity determined by LES. The strong velocities measured provided evidence
to dispute previously assumed safe separation distances, and therefore, there is incentive
to develop more viable infection prevention methods. The average spread angle of 24°
obtained experimentally was comparable to the values previously published for steady
free jets, where a spreading angle between 20-35° is typically measured (Ball et al 2012).
No statistically significant differences were observed in the velocity or turbulence
characteristics between coughs from sick or healthy participants and evidence was
provided to support the claim that velocity data obtained from healthy participants in
previous studies can be used to approximate the flow field of coughs from individuals who
have been infected with respiratory viruses.
The biological air sampling method used in this study was unable to assess the relative
significance of far field virus transmission. This could mean that that three forced
coughing events do not produce a significant amount of viral droplet, or it is possible that
the virus was present but not sampled due to the small area of the sampling cassettes.
There is also a possibility that the air sampling method used destroyed the viral particles
upon impaction and, perhaps in future investigations, more coughs should be sampled,
or an alternative sampling method should be used.
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Chapter 4

4

Spatially averaged velocity time histories

The spatially averaged velocity magnitude, [V], and the u-component velocity in the xdirection, <ux>, were computed. The magnitudes and normalized profiles were compared
with the CFD data obtained from the URANS and LES simulations. The spatial data
provided here further contributed to the cough jet model, and an average span-wise
velocity distribution was determined.

4.1 Spatial averages within width of cough jet
The following section details the results and the method used to obtain the spatially
averaged velocity time histories.

4.1.1

Method for calculating spatial averages

To determine the spatially averaged velocity time histories from the PIV data, the upper
and lower boundaries of the cough jet flow field were selected at the point in the cough
where the jet width reached a maximum. Boundaries were set to be the locations where
the velocity decreased to 0.05 m/s, and a visualization of this averaging window is shown
in Figure 24. Coughs were excluded from the analysis if the width of the jet was not
completely contained within the field of view, and if the peak centerline instantaneous
velocity, Vpeak, was below 0.2 m/s. The average velocities were then computed according
to Equation 4.1, and they were normalized according to Equation 4.2 and Equation 4.3
using the same method described in Chapter 3. The spatial averages were also computed
for the LES and URANS data, using the same method.
[𝑉] =

∑𝑛
1 𝑉𝑖
𝑛

where: n is the number of vectors within the PIV window,
𝑉𝑖 = √(𝑢𝑖 )2 + (𝑣𝑖 )2

(4.1)
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[𝑉](𝑡)−[𝑉]𝑠

[𝑉]𝑛𝑜𝑟𝑚 = [𝑉]

𝑝𝑒𝑎𝑘 −[𝑉]𝑠

(4.2)

where: [V]s is the residual spatially averaged velocity within the chamber at t=0,
[V]peak is the maximum velocity at the peak of the cough.
𝜏=𝑡

𝑡

𝑝𝑒𝑎𝑘−𝑠

Where tpeak-s is the time at which [V]peak is observed.

(4.3)
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Figure 24: Contour of velocity magnitude and overlaid vectors with spatial averaging
window

4.1.2

Results and discussion

The values for [V]peak obtained experimentally were between 0.13 m/s and 1.10 m/s, and
the averages are displayed in Table 13. Although it seems like the “sick” cohort produced
coughs that were stronger than the other cohorts, the difference was probably attributed
to statistical issues with a low number of coughs used for the analysis. However, the
average value obtained from all 106 good coughs are compared with the values achieved
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from the CFD data in Table 14. It is expected that if more participants were recruited for
the “sick” cohort, the value would shift toward the achieved average. The values obtained
experimentally were very similar to the values obtained from CFD, further demonstrating
the accuracy of the model.

Table 13: Average maximum spatially averaged velocity magnitudes, [V]peak, and
number of coughs used for analysis from each cohort
Cohort
2018 Sick
2018 Convalescent
2018 Healthy
All cohorts

Number of
subjects
7
7
25
39*

Number of good
coughs
13
21
72
106

Average maximum
[V], m/s
0.58
0.42
0.46
0.48

*39 sets of experiments from 32 different subjects

Table 14: Maximum spatially averaged velocity magnitude, [V]peak, for LES and URANS
simulations
Simulation (CFD)
LES
URANS

Maximum [V] (m/s)
0.46
0.47

The time histories for the spatially averaged velocity magnitude, [V], are displayed in
Figure 25. It is evident that the numerical simulations were contained within the range of
experimental data, although, the LES provided a better representation of a “real” cough.
This was confirmed by the normalized profiles displayed in Figure 26, where the LES
normalized velocity time history was closer to the average PIV time history. However,
both CFD simulations had normalized velocities greater than the average PIV
dimensionless time histories in the region 0 < τ < 1. This did not necessarily provide
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evidence against the validity of the models since, the instantaneous time histories are
expected to deviate slightly from the average values.

Figure 25: Time histories of spatially averaged velocity magnitude (all 106 good coughs
from all cohorts, along with data from LES and URANS simulations)
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Figure 26: Normalized spatially averaged velocity magnitude for all 106 good coughs
obtained experimentally and data obtained from LES and URANS simulations

4.2 Directionally averaged velocity profiles
The following section details the directionally averaged profiles determined and the
method used to obtain them.

4.2.1

Method for calculating directional averages

The u-component velocity was averaged across all x values for each y-position according
to Equation 4.4. The process was repeated for each image, and Figure 27 displays a
visualization of this method.
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< 𝑢𝑥 > (𝑦) =

∑18
1 𝑢𝑖 (𝑦)
18

(4.4)

Figure 27: Velocity magnitude contour with visualization of directional averaging
process
After each value was computed, the velocity profile was plotted for each image of every
cough. The profiles were normalized using Equation 4.5 and Equation 4.6, and they were
translated vertically so that the peak value occurs at the centerline. The v-component
velocity was also averaged across y for each x value, but the resulting profiles did not yield
any useful information and, therefore, did not contribute to the model.
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<𝑢 >(𝑦)

< 𝑢𝑥 ′ > (𝑦) = <𝑢 𝑥>

𝑥 𝑝𝑒𝑎𝑘

(4.5)

Where:
<ux>peak is the maximum directionally averaged velocity at the peak of the cough.
𝜏=𝑡

𝑡

𝑝𝑒𝑎𝑘−𝑑

(4.6)

Where:
tpeak-d is the time at which <ux>peak is observed.

4.2.2

Results and discussion

A typical directionally averaged velocity profiles is displayed in Figure 28. It was evident
that for many cases, the averaged velocities at the edges of the jet were slightly negative
values. This occurred because as the mass of fluid moves through its surroundings,
vortices are formed at the shear layers, where the velocity gradients are greatest. Since
the averaging window is small enough that the velocity does not change substantially in
the x-direction, the slightly negative average values were expected as the ambient fluid is
entrained into the jet. The normalized average u-velocity profiles are plotted and
compared with the profiles obtained from the CFD simulations for select values of τ in
Figure 29. It was evident that there were some limitations involved with the averaging
method used. The maximum directionally averaged cough velocity did not necessarily
occur at the apparent cough jet centre, which caused some of the profiles to favour one
side. Despite this, the CFD simulations showed were within the range of experimental
results for each time step, further indicating the validity of using these span-wise
distributions for the development of a model.
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Figure 28: u-Component velocity averaged in the x-direction and plotted with y
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(a)
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(b)
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(c)
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(d)
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(f)
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(g)
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(h)

Figure 29: Normalized u-component velocity averaged across x for (a) τ=0.0; (b)
τ=0.25; (c) τ=0.5; (d) τ=0.75; (e) τ=1.0; (f) τ=1.5; (g) τ=2.0; (h) τ=2.5
The half-velocity diameter at the peak of the cough, δ 1/2, normalized by an average mouth
diameter of D=0.0217m (Gupta et al. 2009), is displayed in Table 15. The PIV and LES
results exhibited very similar values for δ 1/2/D, whereas the URANS simulation achieved
a value that was closer to the δ 1/2/D value obtained experimentally for a steady, turbulent
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free-jet. This likely occurs due to the simplifications that are utilized with the URANS
method.
Table 15: Dimensionless half axial velocity widths for experimental (PIV), numerical
(CFD) and steady jets at x=45D
Data
Average experimental (PIV)
LES
URANS
Steady jet, Re=5000
(Ghaem-Maghami et al. 2010)

δ 1/2/D, at x/D=45
5.07
5.53
10.60
9.00

4.3 Conclusions
The spatially averaged velocity time histories and the directionally averaged velocity
profiles were computed and compared with the results obtained from the URANS and LES
simulations. The range of experimental peak spatially averaged velocities, [V]peak, was
between 0.13 and 1.10 m/s with an average of 0.48 m/s. This was comparable to the value
obtained from LES (0.46 m/s) and URANS (0.47 m/s) simulations. The normalized velocity
time histories showed agreement between the numerical and experimental data,
providing further validation for the simulation.
The normalized profiles u-component velocities averaged across x, were used to model
the span-wise velocity distribution for the cough jets examined. The half velocity diameter
obtained experimentally was similar to the value obtained from LES (δ1/2/D=5.07 for PIV,
δ1/2/D=5.53 for LES), whereas the value achieved by the URANS simulation showed
characteristics similar to those obtained experimentally for a steady jet, at the same x/D.
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Chapter 5

5

Conclusions and recommendations

5.1 Conclusions
After reviewing the methods used in prior investigations, particle image velocimetry (PIV)
was determined to be the most suitable tool for spatially resolving velocity fields due to
its accuracy, and the non-intrusiveness of the measurement technique. It was difficult to
distinguish between particles produced by coughing, and those used to seed the flow in
the experiments, so droplet sizing and biological sampling could not be conducted in the
same trials as airflow measurements. Limitations in the available experimental
techniques were demonstrated for sizing and counting expired particles however, several
conclusions could be made following the review. An average peak flow rate of
approximately 7.0 L/s, was measured by several investigations and, based on a measured
mouth opening area of 4.0 cm2, a peak velocity of approximately 17.5 m/s at the mouth
is reasonable to use in any physical or computational model.
Throughout the investigation, a total of 77 experiments were conducted from 58 different
subjects. From these subjects, 21 presented with influenza like illness, 12 of whom had
laboratory confirmed respiratory infections. In the experiments, 177 coughs were
measured using PIV, 171 using HWA and 63 were sampled with PTFE filter cassettes.
By combining the experimental measurements and data obtained from previous CFD
simulations, a complete model for the cough centreline velocity and the span-wise
velocity distribution has been developed. A high degree of variability was observed
between individual coughs, but the average profiles were a good representation of the
expiratory airflow field produced by a human cough in the region x ≥ 12d. This
approximate location can be used to distinguish between near-field and far-field cough
jet behaviour. An average peak velocity of 1.17 m/s was observed at the cough centre
(maximum 3.05 m/s), 1.0 m downstream, which is comparable to the 1.07 m/s velocity
determined by LES. The strong velocities measured provided evidence to dispute
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previously assumed safe separation distances and, therefore, there is incentive to
develop better infection prevention methods. The average spread angle of 24° obtained
experimentally was comparable to the values previously published by other researchers.
The half velocity diameter obtained experimentally was similar to the value obtained from
LES (δ1/2/D=5.07 for PIV, δ 1/2/D=5.53 for LES), whereas the value achieved by the URANS
simulation showed characteristics similar to those obtained experimentally for a steady
jet, at the same x/D. The spatially averaged velocity time histories and the directionally
averaged velocity profiles were computed and compared with the results obtained from
the URANS and LES simulations. The range of experimental peak spatially averaged
velocities, [V]peak, was between 0.13 and 1.10 m/s with an average of 0.48 m/s. This was
comparable to the value obtained from LES (0.46 m/s) and URANS (0.47 m/s) simulations.
The normalized velocity time histories and the span-wise velocity distributions showed
agreement between the numerical and experimental data indicating the validity of the
simulations.
No differences were observed in the velocity or turbulence characteristics between
coughs from sick or healthy participants which means velocity data obtained from healthy
participants in previous studies can be used to approximate the flow field of coughs from
individuals who have been infected with respiratory viruses.
The biological air sampling methods used in this study was unable to assess the relative
significance of far field virus transmission, and the objective of quantifying the risk of
exposure to viable viruses was not met. It is possible that three forced coughing events
did not produce substantial quantities of viral droplets, but it is likely that viruses were
present but not sampled due to the small area of the sampling cassettes. There is also a
possibility that the air sampling method used destroyed the viral particles upon
impaction.
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5.2 Recommendations
In future investigations, measurements of cough airflows should be conducted at greater
distances to assess the validity of the present model further downstream, and to
determine evidence-based infection prevention protocols. It would also be beneficial to
conduct experiments at multiple locations within a single cough flow field to obtain
quantitative and qualitative information on the development of these transient cough
jets.
Since the risk of exposure to viable viral aerosols could not be quantified, alternative
methods for sampling cough droplets in the far-field should be investigated. Perhaps
during the sampling period, participants should be asked to provide a greater number of
coughs, increasing the chance that viruses are collected by the present apparatus. Since,
not all people produce the same quantity of droplets by coughing, a possible objective in
the future could be to identify host determinants of people who emit higher
concentrations of viable viral aerosols (“super-spreaders”).
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Appendices
Appendix A: Hot-wire anemometry (HWA) uncertainty estimates
The following subsection summarizes the uncertainty and error experienced by a HWA
velocity measurement. A detailed description of the method used is available in
Mohamed (2017). Table A1 shows the relative standard uncertainties associated with
each source of error. It was evident that the calibration process primarily contributes to
the uncertainty. The maximum overall combined standard uncertainty for HWA velocity
measurements was determined to be 5.4% using the root sum square method described
by Coleman & Steele (2009).
Table A1: Relative standard uncertainties for each source of error for HWA
measurements
Source

Quantity

Calibration

Theoretical
velocity, Vth
Voltage; bit
depth, EAD; a
Temperature,
ΔT

A/D resolution
Variation in
sensor
temperature
Ambient
temperature
variations
Ambient
pressure

Relative
standard
uncertainty
0.0538
0.00116
0.0043

Temperature,
ΔT

0.0023

Pressure, ΔP

0.00045
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Appendix B: Particle image velocimetry error and uncertainty calculation
The following subsection summarizes the method used to estimate the uncertainty
associated with the experimental PIV measurements. A detailed description of the
method used is available in Khadivi (2012) and Mohamed (2017). A typical example of the
axial and vertical velocity gradients was used for the estimation of error. Table B1 displays
the pixel errors associated for each source of error. Overall, a velocity error of 0.04 m/s
was associated with the sum of pixel errors in this representative cough. Based on a
velocity of V=1.1 m/s, an error of 3.6% was observed.
Table B1: Pixel errors associated with each source of error for PIV measurements
Source
Velocity gradient
error
Particle diameter
Peak locking error
Out of plane
motion error

Quantity
εV

Pixel error
0.011

εdp
εpl
εop

0.015
0
0
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